Physician profile
Lisbeth Keplinger
NPI 1053571828
$53,699.26
in general payments reported to CMS, 2019-2025
14 companies · $3,772 in 2025
The $3,772 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,124 · 2022: $1,644 · 2023: $39K · 2024: $5,172 · 2025: $3,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Travel and Lodging: $8,367 · Food and Beverage: $3,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,399.52 |
| Travel and Lodging | $8,367.03 |
| Food and Beverage | $3,164.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $48,331.76 | 2019-2025 | Portfolio, Bun-Yo-Matic, Paratrooper |
| Arthrex, INC. | $3,501.98 | 2019 | |
| Stryker Corporation | $909.31 | 2022-2023 | Prostep, Citrefix, Easyfuse |
| Smith+Nephew, INC. | $194.19 | 2019-2024 | Stravix |
| Vital Orthopedics LLC | $136.34 | 2025 | |
| Nevro Corp. | $135.40 | 2022 | |
| Horizon Therapeutics Plc | $112.22 | 2019 | |
| Pfizer INC. | $109.20 | 2019 | |
| Fusion Orthopedics USA, LLC | $88.32 | 2025 | |
| Scilex Pharmaceuticals INC. | $64.87 | 2019 | |
| Integra Lifesciences Corporation | $51.44 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $32.43 | 2019 | |
| Bioventus LLC | $16.14 | 2019 | |
| Empire Medical, INC | $15.66 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisbeth Keplinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.